| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 78.086 | 85.883 | 549.603 | 1.419.580 | 2.392.150 | 4.148.997 | 3.398.068 | 3.353.816 |
| Total Income - EUR | - | - | 78.088 | 85.887 | 549.614 | 1.419.892 | 2.392.705 | 4.152.955 | 3.403.154 | 3.684.488 |
| Total Expenses - EUR | - | - | 60.090 | 33.622 | 237.445 | 1.065.408 | 1.037.956 | 2.583.340 | 2.027.287 | 2.127.355 |
| Gross Profit/Loss - EUR | - | - | 17.998 | 52.264 | 312.169 | 354.484 | 1.354.749 | 1.569.615 | 1.375.867 | 1.557.134 |
| Net Profit/Loss - EUR | - | - | 15.655 | 49.687 | 306.751 | 348.338 | 1.163.297 | 1.322.219 | 1.152.840 | 1.310.717 |
| Employees | - | - | 0 | 0 | 1 | 1 | 3 | 4 | 7 | 8 |
Check the financial reports for the company - Solviamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 21 | 0 | 0 | 557 | 261.636 | 279.583 | 273.653 | 53.824 |
| Current Assets | - | - | 17.427 | 65.098 | 353.082 | 561.957 | 2.324.603 | 3.196.735 | 3.293.988 | 3.219.252 |
| Inventories | - | - | 0 | 16.999 | 110.480 | 62.977 | 347.323 | 77.617 | 386.230 | 505.740 |
| Receivables | - | - | 5.563 | 27.198 | 51.788 | 265.617 | 1.782.426 | 2.253.343 | 735.552 | 1.627.969 |
| Cash | - | - | 11.864 | 20.901 | 190.814 | 233.363 | 194.853 | 865.775 | 2.172.206 | 1.085.544 |
| Shareholders Funds | - | - | 15.699 | 65.098 | 306.948 | 431.833 | 1.479.158 | 1.322.268 | 1.189.896 | 1.310.765 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.749 | 0 | 46.313 | 130.754 | 1.107.081 | 2.154.053 | 2.377.746 | 1.962.311 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Solviamed S.r.l.